Bayer CropScience Ltd (BAYERCROP) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 491198,
    "name": "Bayer CropSci.",
    "stock_name": "Bayer CropSci.",
    "full_name": "Bayer CropScience Ltd",
    "name_url": "stocks-analysis/bayer-cropsci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,422.00",
    "chg": 3.7,
    "chgp": "0.08%",
    "dir": 1,
    "prev_price": "4,418.30",
    "mcapval": "19,873.39 Cr",
    "mcap": "Small Cap",
    "scripcode": 506285,
    "symbol": "BAYERCROP",
    "ind_name": "Pesticides & Agrochemicals",
    "ind_code": 18,
    "indexname": "",
    "isin": "INE462A01022",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "28.23 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/bayer-cropsci-491198-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Bayer CropSci. Sees Revision in Market Evaluation Amid Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bayer-cropsci-downgraded-to-sell-by-marketsmojo-amid-weak-financial-and-technical-trends-3733147",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BayerCropSci_mojoScore_3733147.png",
        "date": "2025-11-27 10:06:18",
        "description": "Bayer CropSci., a small-cap player in the Pesticides & Agrochemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment follows a period marked by subdued growth and valuation concerns, prompting a reassessment of the company’s standing within its industry."
      },
      {
        "title": "Why is Bayer CropSci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bayer-cropsci-fallingrising-3690954",
        "imagepath": "",
        "date": "2025-11-11 22:56:39",
        "description": "As of 11-Nov, Bayer CropScience Ltd is experiencing a decline in its stock price, currently at Rs 4,506.85, which reflects a decrease of 131.1 points or 2.83%. The stock has underperformed its sector by 2.4% today, touching an intraday low of Rs 4,490, which is a drop of 3.19%. Over the past week, the stock has seen a return of -6.81%, and its performance over the last month is also negative at -9.92%. Despite a rise in investor participation, with delivery volume increasing by 90.59% against the 5-day average, the stock is trading below all key moving averages, indicating a bearish trend. Additionally, the company has shown poor long-term growth, with operating profit declining at an annual rate of -3.22% over the last five years, and recent financial results have been flat, contributing to the negative sentiment surrounding the stock.\n\nIn the broader market context, Bayer CropScience's performance contras..."
      },
      {
        "title": "How has been the historical performance of Bayer CropSci.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-bayer-cropsci-3683542",
        "imagepath": "",
        "date": "2025-11-09 22:41:31",
        "description": "Answer:\nThe historical performance of Bayer CropSci. shows a trend of increasing net sales and operating income over the years, with net sales reaching 5,473.40 Cr in March 2025, up from 5,106.20 Cr in March 2024 and 5,139.70 Cr in March 2023. However, operating profit (PBDIT) has seen a decline from 1,035.00 Cr in March 2024 to 809.30 Cr in March 2025. Profit before tax also decreased to 707.40 Cr in March 2025 from 941.40 Cr in March 2024, while profit after tax fell to 568.00 Cr from 740.50 Cr in the same period. The company's total assets increased to 5,236.20 Cr in March 2025, compared to 4,597.10 Cr in March 2024, indicating growth in the asset base. Total liabilities also rose to 5,236.20 Cr from 4,597.10 Cr, reflecting an increase in financial obligations. Cash flow from operating activities decreased significantly to 262.00 Cr in March 2025 from 951.00 Cr in March 2024, contributing to a net cash o..."
      },
      {
        "title": "Are Bayer CropSci. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-bayer-cropsci-latest-results-good-or-bad-3682447",
        "imagepath": "",
        "date": "2025-11-08 19:19:58",
        "description": "Bayer CropScience's latest financial results for Q2 FY26 highlight significant operational trends, particularly influenced by the seasonal nature of the agrochemicals business. The company reported net sales of ₹1,914.60 crores, reflecting a substantial sequential increase of 82.97% from the previous quarter, driven by heightened demand during the kharif sowing season. Year-on-year, revenue growth stood at 17.36%, indicating resilience in maintaining market share amidst competitive pressures.\n\nNet profit for the same quarter reached ₹278.70 crores, which is a notable increase of 94.50% quarter-on-quarter and 9.64% year-on-year. However, despite these positive profit figures, the operating margin experienced compression, standing at 18.20%. This represents a sequential improvement but a decline compared to the previous year, suggesting challenges in maintaining profitability amidst rising costs or competitiv..."
      },
      {
        "title": "Bayer CropScience Q2 FY26: Strong Quarter Masks Underlying Margin Pressure",
        "link": "https://www.marketsmojo.com/news/result-analysis/bayer-cropscience-q2-fy26-strong-quarter-masks-underlying-margin-pressure-3680609",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BayerCropScienc_quaterlyResult_3680609.png",
        "date": "2025-11-07 20:02:48",
        "description": "Bayer CropScience Ltd., a prominent player in India's pesticides and agrochemicals sector, reported a net profit of ₹278.70 crores for Q2 FY26 ended June 2025, marking a sequential surge of 94.50% from the preceding quarter's ₹143.30 crores. On a year-on-year basis, the company posted a 9.64% increase from ₹254.20 crores in Q2 FY25. Despite these headline gains, the stock has faced significant headwinds, plunging 30.80% over the past year and currently trading at ₹4,604.15 with a market capitalisation of ₹21,078 crores. The results reveal a company navigating seasonal volatility whilst grappling with margin compression that has persisted across multiple quarters."
      },
      {
        "title": "Why is Bayer CropSci. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bayer-cropsci-fallingrising-3676981",
        "imagepath": "",
        "date": "2025-11-06 22:45:25",
        "description": "As of 06-Nov, Bayer CropScience Ltd's stock price is currently at Rs 4,754.70, reflecting a decline of Rs 81.4 or 1.68%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decrease of 3.3% over the past week. It has also touched an intraday low of Rs 4,730, which represents a 2.19% drop. In terms of performance against benchmarks, Bayer has seen a significant decline, with a year-to-date return of -14.39% and a one-year return of -28.33%, both of which are considerably worse than the Sensex's positive returns. The stock is trading below all its moving averages, indicating a bearish trend, and there has been a decrease in investor participation, with delivery volume falling by 4.65% compared to the five-day average.\n\nIn the broader market context, Bayer's short-term performance is notably worse than the Sensex, which has seen a decline of only 1.30% o..."
      }
    ],
    "total": 592,
    "sid": "491198",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/bayer-cropscience-491198"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "27-Jan-2026",
      "details": "Bayer Cropscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve The Unaudited Financial Results of the Company for the quarter ended on December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Update To The Disclosure Made Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "22-Jan-2026",
      "details": "In furtherance to the disclosure made by the Company on December 18 2023 and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Company had filed an appeal to the Customs Excise and Service Tax Authority Appellate Tribunal (CESAT/ Appellate Authority) against the impugned order received from the Office of Commissioner of Customs Centralized Adjudication Cell Maharashtra imposing penalty of Rs. 100 Mio on the Company. The Appellate Authority vide its final order dated January 20 2026 (received by the Company on January 21 2026) has set aside the impugned order. The details as required under SEBI Listing Regulations read with SEBI Circular dated July 13 2023 are enclosed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jan-2026",
      "details": "Attached the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bayer CropScience Ltd has declared <strong>900%</strong> dividend, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bayer CropSci. Sees Revision in Market Evaluation Amid Challenging Financial Trends

2025-11-27 10:06:18

Bayer CropSci., a small-cap player in the Pesticides & Agrochemicals sector, has experienced a revision in its market evaluation reflecting shifts in its financial and technical outlook. This adjustment follows a period marked by subdued growth and valuation concerns, prompting a reassessment of the company’s standing within its industry.

Why is Bayer CropSci. falling/rising?

2025-11-11 22:56:39

As of 11-Nov, Bayer CropScience Ltd is experiencing a decline in its stock price, currently at Rs 4,506.85, which reflects a decrease of 131.1 points or 2.83%. The stock has underperformed its sector by 2.4% today, touching an intraday low of Rs 4,490, which is a drop of 3.19%. Over the past week, the stock has seen a return of -6.81%, and its performance over the last month is also negative at -9.92%. Despite a rise in investor participation, with delivery volume increasing by 90.59% against the 5-day average, the stock is trading below all key moving averages, indicating a bearish trend. Additionally, the company has shown poor long-term growth, with operating profit declining at an annual rate of -3.22% over the last five years, and recent financial results have been flat, contributing to the negative sentiment surrounding the stock. In the broader market context, Bayer CropScience's performance contras...

How has been the historical performance of Bayer CropSci.?

2025-11-09 22:41:31

Answer: The historical performance of Bayer CropSci. shows a trend of increasing net sales and operating income over the years, with net sales reaching 5,473.40 Cr in March 2025, up from 5,106.20 Cr in March 2024 and 5,139.70 Cr in March 2023. However, operating profit (PBDIT) has seen a decline from 1,035.00 Cr in March 2024 to 809.30 Cr in March 2025. Profit before tax also decreased to 707.40 Cr in March 2025 from 941.40 Cr in March 2024, while profit after tax fell to 568.00 Cr from 740.50 Cr in the same period. The company's total assets increased to 5,236.20 Cr in March 2025, compared to 4,597.10 Cr in March 2024, indicating growth in the asset base. Total liabilities also rose to 5,236.20 Cr from 4,597.10 Cr, reflecting an increase in financial obligations. Cash flow from operating activities decreased significantly to 262.00 Cr in March 2025 from 951.00 Cr in March 2024, contributing to a net cash o...

Are Bayer CropSci. latest results good or bad?

2025-11-08 19:19:58

Bayer CropScience's latest financial results for Q2 FY26 highlight significant operational trends, particularly influenced by the seasonal nature of the agrochemicals business. The company reported net sales of ₹1,914.60 crores, reflecting a substantial sequential increase of 82.97% from the previous quarter, driven by heightened demand during the kharif sowing season. Year-on-year, revenue growth stood at 17.36%, indicating resilience in maintaining market share amidst competitive pressures. Net profit for the same quarter reached ₹278.70 crores, which is a notable increase of 94.50% quarter-on-quarter and 9.64% year-on-year. However, despite these positive profit figures, the operating margin experienced compression, standing at 18.20%. This represents a sequential improvement but a decline compared to the previous year, suggesting challenges in maintaining profitability amidst rising costs or competitiv...

Bayer CropScience Q2 FY26: Strong Quarter Masks Underlying Margin Pressure

2025-11-07 20:02:48

Bayer CropScience Ltd., a prominent player in India's pesticides and agrochemicals sector, reported a net profit of ₹278.70 crores for Q2 FY26 ended June 2025, marking a sequential surge of 94.50% from the preceding quarter's ₹143.30 crores. On a year-on-year basis, the company posted a 9.64% increase from ₹254.20 crores in Q2 FY25. Despite these headline gains, the stock has faced significant headwinds, plunging 30.80% over the past year and currently trading at ₹4,604.15 with a market capitalisation of ₹21,078 crores. The results reveal a company navigating seasonal volatility whilst grappling with margin compression that has persisted across multiple quarters.

Why is Bayer CropSci. falling/rising?

2025-11-06 22:45:25

As of 06-Nov, Bayer CropScience Ltd's stock price is currently at Rs 4,754.70, reflecting a decline of Rs 81.4 or 1.68%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decrease of 3.3% over the past week. It has also touched an intraday low of Rs 4,730, which represents a 2.19% drop. In terms of performance against benchmarks, Bayer has seen a significant decline, with a year-to-date return of -14.39% and a one-year return of -28.33%, both of which are considerably worse than the Sensex's positive returns. The stock is trading below all its moving averages, indicating a bearish trend, and there has been a decrease in investor participation, with delivery volume falling by 4.65% compared to the five-day average. In the broader market context, Bayer's short-term performance is notably worse than the Sensex, which has seen a decline of only 1.30% o...

View All News

Announcement

Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

27-Jan-2026 | Source : BSE

Bayer Cropscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve The Unaudited Financial Results of the Company for the quarter ended on December 31 2025.

Update To The Disclosure Made Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015

22-Jan-2026 | Source : BSE

In furtherance to the disclosure made by the Company on December 18 2023 and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Company had filed an appeal to the Customs Excise and Service Tax Authority Appellate Tribunal (CESAT/ Appellate Authority) against the impugned order received from the Office of Commissioner of Customs Centralized Adjudication Cell Maharashtra imposing penalty of Rs. 100 Mio on the Company. The Appellate Authority vide its final order dated January 20 2026 (received by the Company on January 21 2026) has set aside the impugned order. The details as required under SEBI Listing Regulations read with SEBI Circular dated July 13 2023 are enclosed herewith.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

07-Jan-2026 | Source : BSE

Attached the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended December 31 2025.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

Bayer CropScience Ltd has declared 900% dividend, ex-date: 14 Nov 25

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support@mojoinfinity.com, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."